e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Advances in asthma and allergy in animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytomegalovirus (CMV) modulates the immune responses against inhaled harmless antigens
Sebastian Reuter (Mainz, Germany), Sebastian Reuter, Helen Meyer-Martin, Hendrik Beckert, Christian Taube, Roland Buhl, Rafaela Holtappels
Source:
International Congress 2015 – Advances in asthma and allergy in animal models
Session:
Advances in asthma and allergy in animal models
Session type:
Oral Presentation
Number:
2008
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sebastian Reuter (Mainz, Germany), Sebastian Reuter, Helen Meyer-Martin, Hendrik Beckert, Christian Taube, Roland Buhl, Rafaela Holtappels. Cytomegalovirus (CMV) modulates the immune responses against inhaled harmless antigens. Eur Respir J 2015; 46: Suppl. 59, 2008
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The monocyte-dependent immune response to bacterial infections is systemically suppressed in COPD
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014
Adjuvant BCG immunotherapy induces an effective antiviral immune response in recurrent respiratory papillomatosis
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Innate immune response to respiratory syncytial virus and human rhinovirus in infants: Similarities and differences its effect on disease severity
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014
Immune modulation of the T-cell response in asthma through Wnt10b
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Antibody responses to rhinovirus and echovirus antigens in children with asthma exacerbations
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Alterations to innate immunity in patients with bronchiectasis
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Investigation of the innate antiviral response to respiratory syncytial virus
Source: International Congress 2015 – Paediatric pulmonary infections: mechanisms and treatment
Year: 2015
Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
HMGB1 expression and function in the allergic airway immune response
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
Gamma globulin (Ig) replacement– a potential treatment in uncontrolled asthma associated with humoral immunodeficiency (huID)?
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Cellular and humoral immune response in non HIV infected tuberculous patients in Upper Egypt
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
Modulation of PD-1 and PD-L1 expression in response to acute viral infection of human lung tissue
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Importance of immunostimulation for community acquired pneumonia management
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Eotaxin-3 exerts innate host defense activities that are modulated by mast cell proteases
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
NLRP3 inflammasome-mediated, IL-1β-dependent inflammatory responses drive steroid-resistant asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
Evaluation of IFNgamma release assays for detection of cellular immunity towards
M. tuberculosis
and CMV in samples from deceased donors
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Liposomal local therapy of upper respiratory tract involvement in ANCA associated vasculitis
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Identification of viral species in asthma patients with and without aspirin hypersensitivity
Source: Annual Congress 2013 –Viral infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept